Skip to main content

Waters Corporation (WAT) Stock Analysis

HoldModerate Confidence

Healthcare · Diagnostics & Research

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology... Read more

$302.32+11.9% upside
Score 5.7/10Target $338.34Reward/Risk 1.3:1

TrendMatrix rates Waters Corporation (WAT) as Hold with moderate confidence. The stock trades at $302.32 with +11.9% upside to the $338.34 price target. Overall score: 5.7/10 across 10 analysis dimensions. Reward/risk ratio: 1.3:1.

Passes 4/6 gates (positive momentum, clean insider activity, positive momentum, no SEC red flags). Fails on favorable risk/reward ratio. Suitability: moderate.

Val4.9Qual7.7Grw2.8Mom5.5Sent8.3Ins7.0Peer3.7Tech5.0Risk7.05.7OVERALL

Investment Thesis

+ V7 quality resilience bonus: +0.2 (Q=7.7 in RISK_OFF)
+ Sector modifier (): +1.2
+ Strong earnings beat streak (4/4)
- Weak growth
- Below 200-day MA

Fundamentals

P/E (TTM)28.1
P/E (Fwd)18.4
Mkt Cap$29.7B
EV/EBITDA27.9
Profit Mgn20.3%
ROE29.3%
Rev Growth6.8%
Beta1.20
DividendNone
Analysts28
Frequently Asked Questions
Is WAT stock a buy right now?

TrendMatrix rates Waters Corporation (WAT) as Hold with moderate confidence. Score 5.7/10.

What is the WAT stock price target?

Take-profit target: $338.34 (+11.9% upside). Reward/risk ratio: 1.3:1. Stop-loss: $274.29.

What are the risks of investing in WAT?

Weak growth; Below 200-day MA.

Is WAT overvalued or undervalued?

Waters Corporation trades at a P/E of 28.1 (forward 18.4). TrendMatrix value score: 4.9/10. Verdict: Hold.

What do analysts say about WAT?

28 analysts cover WAT with a consensus score of 3.9/5. Average price target: $398.

What does Waters Corporation do?Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates...

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Related stocks: MEDP (Medpace Holdings, Inc.) · GH (Guardant Health, Inc.) · BLLN (BillionToOne, Inc.) · SHC (Sotera Health Company) · MTD (Mettler-Toledo International, I)
39 NEUTRAL
<20d<50d<200dDEATH CROSSSupp $282.77Res $323.29

Price Targets

$274
$338
Upside+11.9%
Reward/Risk1.3:1

Position Sizing

ConvictionNONE
Suggested %0.5%
Max %1%
RegimeRISK_OFF

Risk Alerts

! ASYMMETRY:1.8<2.0
Suitability: Moderate
Momentum 5.5>=5.0
Insider activity: OK
Death cross (50MA < 200MA)
No SEC red flags
Death cross (50MA < 200MA)
Risk/Reward 1.8<2.0